Immune Response to Systemic and Mucosal Antigenic Challenge in the Presence of Vedolizumab

NCT01981616 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

127

Enrollment

INDUSTRY

Sponsor class

Conditions

Inflammatory Bowel Disease

Interventions

DRUG: Vedolizumab
DRUG: Placebo
BIOLOGICAL: Hepatitis B vaccine
BIOLOGICAL: Oral cholera vaccine

Sponsor

Millennium Pharmaceuticals, Inc.